Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients

Perit Dial Int. 2000 Sep-Oct;20(5):566-8.

Authors

M Casey¹, J Taylor, P Clinard, A Graham, V Mauck, L Spainhour, P Brown, J Burkart

Affiliation

¹ Section on Nephrology, Wake Forest University School of Medicine, and Piedmont Dialysis Center, Inc., Winston-Salem, North Carolina, USA. mjcasey@wfubmc.edu

PMID: 11117248

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Administration, Topical
Adult
Aged
Anti-Bacterial Agents / administration & dosage*
Bacterial Infections / drug therapy*
Bacterial Infections / etiology
Bacterial Infections / prevention & control
Catheters, Indwelling*
Emulsions
Female
Follow-Up Studies
Humans
Male
Middle Aged
Mupirocin / administration & dosage*
Peritoneal Dialysis / adverse effects*
Peritonitis / drug therapy*
Peritonitis / etiology
Peritonitis / prevention & control
Reference Values
Treatment Outcome

Substances

Anti-Bacterial Agents
Emulsions
Mupirocin